| SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas K Magnusson, M De Wit, DJ Brennan, LB Johnson, SF McGee, ... The American journal of surgical pathology 35 (7), 937-948, 2011 | 266 | 2011 |
| TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression AH Sillars-Hardebol, B Carvalho, M Tijssen, JAM Beliën, M de Wit, ... Gut 61 (11), 1568-1575, 2012 | 170 | 2012 |
| The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study A Dragomir, M De Wit, C Johansson, M Uhlen, F Pontén American journal of clinical pathology 141 (5), 630-638, 2014 | 151 | 2014 |
| The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context TBM Schaaij-Visser, M De Wit, SW Lam, CR Jiménez Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2242-2258, 2013 | 137 | 2013 |
| Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications M de Wit, RJA Fijneman, HMW Verheul, GA Meijer, CR Jimenez Clinical biochemistry 46 (6), 466-479, 2013 | 129 | 2013 |
| Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression AH Sillars-Hardebol, B Carvalho, M de Wit, C Postma, ... Tumor Biology 31, 89-96, 2010 | 114 | 2010 |
| Whole gel processing procedure for GeLC-MS/MS based proteomics JCR Piersma SR, Warmoes MO, de Wit M, de Reus I, Knol Proteome Sci. 11 (17), 2013 | 102 | 2013 |
| Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling M de Wit, H Kant, SR Piersma, TV Pham, S Mongera, MPA van Berkel, ... Journal of proteomics 99, 26-39, 2014 | 100 | 2014 |
| Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression M De Wit, CR Jimenez, B Carvalho, JAM Belien, PM Delis-van Diemen, ... Gut 61 (6), 855-864, 2012 | 97 | 2012 |
| Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression J Albrethsen, JC Knol, SR Piersma, TV Pham, M de Wit, S Mongera, ... Molecular & Cellular Proteomics 9 (5), 988-1005, 2010 | 82 | 2010 |
| Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer RJA Fijneman, M De Wit, M Pourghiasian, SR Piersma, TV Pham, ... Clinical Cancer Research 18 (9), 2613-2624, 2012 | 77 | 2012 |
| BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain AH Sillars‐Hardebol, B Carvalho, JAM Beliën, M de Wit, ... The Journal of pathology 226 (3), 442-450, 2012 | 60 | 2012 |
| Novel stool-based protein biomarkers for improved colorectal cancer screening: a case–control study LJW Bosch, M De Wit, TV Pham, VMH Coupé, AC Hiemstra, SR Piersma, ... Annals of Internal Medicine 167 (12), 855-866, 2017 | 53 | 2017 |
| Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer N Snoeren, BL Emmink, MJG Koerkamp, SR van Hooff, JACM Goos, ... British journal of cancer 109 (6), 1636-1647, 2013 | 53 | 2013 |
| Lumican and versican are associated with good outcome in stage II and III colon cancer M de Wit, EJT Belt, PM Delis-van Diemen, B Carvalho, VMH Coupé, ... Annals of surgical oncology 20, 348-359, 2013 | 48 | 2013 |
| MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients K Lenos, JACM Goos, IM Vuist, SH den Uil, PM Delis-van Diemen, J Eric, ... Oncotarget 6 (28), 26278, 2015 | 45 | 2015 |
| CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression AH Sillars-Hardebol, B Carvalho, JAM Beliën, M de Wit, ... Cellular Oncology 35, 293-300, 2012 | 36 | 2012 |
| Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression MA Komor, M de Wit, J van den Berg, SR Martens de Kemp, ... International journal of cancer 146 (7), 1979-1992, 2020 | 35 | 2020 |
| Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression M de Wit, B Carvalho, PM Delis-van Diemen, C van Alphen, JAM Beliën, ... PLoS One 12 (5), e0174768, 2017 | 34 | 2017 |
| Peptide-mediated ‘miniprep’isolation of extracellular vesicles is suitable for high-throughput proteomics JC Knol, I de Reus, T Schelfhorst, R Beekhof, M de Wit, SR Piersma, ... EuPA Open Proteomics 11, 11-15, 2016 | 29 | 2016 |
Gerrit A Meijerprofessor of oncologic pathology, Netherlands Cancer Institute, University Medical Center UtrechtVerified email at nki.nl
